ATE52506T1 - Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung. - Google Patents

Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.

Info

Publication number
ATE52506T1
ATE52506T1 AT87102795T AT87102795T ATE52506T1 AT E52506 T1 ATE52506 T1 AT E52506T1 AT 87102795 T AT87102795 T AT 87102795T AT 87102795 T AT87102795 T AT 87102795T AT E52506 T1 ATE52506 T1 AT E52506T1
Authority
AT
Austria
Prior art keywords
group
sup
defined above
pharmaceutically acceptable
same
Prior art date
Application number
AT87102795T
Other languages
English (en)
Inventor
Toshio Tatsuoka
Kenji Suzuki
Kayoko Imao
Fumio Satoh
Seiji Miyano
Kunihiro Sumoto
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE52506T1 publication Critical patent/ATE52506T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87102795T 1986-02-27 1987-02-27 Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung. ATE52506T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61042732A JPH0723367B2 (ja) 1986-02-27 1986-02-27 オキサビシクロヘプタン誘導体
EP87102795A EP0238883B1 (de) 1986-02-27 1987-02-27 Oxabicycloheptan-Derivate, pharmazeutische Zusammensetzung und Verwendung

Publications (1)

Publication Number Publication Date
ATE52506T1 true ATE52506T1 (de) 1990-05-15

Family

ID=12644212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87102795T ATE52506T1 (de) 1986-02-27 1987-02-27 Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.

Country Status (8)

Country Link
US (1) US4713453A (de)
EP (1) EP0238883B1 (de)
JP (1) JPH0723367B2 (de)
AT (1) ATE52506T1 (de)
CA (1) CA1300138C (de)
DE (1) DE3762621D1 (de)
ES (1) ES2036183T3 (de)
GR (2) GR3000693T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401850A (en) * 1990-06-06 1995-03-28 Suntory Limited Cyclopropachromen derivatives
CA2037188A1 (en) * 1990-06-06 1991-12-07 Toshio Tatsuoka Agent for treating disorders from cerebral neuro-degeneration
JP3054207B2 (ja) * 1990-06-06 2000-06-19 サントリー株式会社 シクロプロパクロメン誘導体
JP3993651B2 (ja) * 1994-10-21 2007-10-17 アスビオファーマ株式会社 シクロプロパクロメンカルボン酸誘導体
AU2005320585A1 (en) * 2004-12-28 2006-07-06 Asubio Pharma Co., Ltd. Process for producing carbon-diminished aldose compound
IT1400964B1 (it) * 2010-06-15 2013-07-05 Dipharma Francis Srl Procedimento per la preparazione di derivati pteridinici
US9833450B2 (en) * 2015-02-19 2017-12-05 Lixte Biotechnology, Inc. Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468897A (en) * 1966-10-05 1969-09-23 Pierre Fournari Certain 6-amino-2-(aryl or heteroaryl)-4-chromanone-hydrazones and derivatives
JPS5829782A (ja) * 1981-08-12 1983-02-22 Nippon Zoki Pharmaceut Co Ltd 新規複素環化合物、その製法及び該化合物を含有する医薬組成物

Also Published As

Publication number Publication date
GR3000693T3 (en) 1991-09-27
ES2036183T3 (es) 1993-05-16
CA1300138C (en) 1992-05-05
US4713453A (en) 1987-12-15
JPH0723367B2 (ja) 1995-03-15
JPS62198676A (ja) 1987-09-02
GR900300046T1 (en) 1991-07-31
EP0238883A1 (de) 1987-09-30
EP0238883B1 (de) 1990-05-09
DE3762621D1 (de) 1990-06-13

Similar Documents

Publication Publication Date Title
DE3788145D1 (de) Piperidinderivate, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung.
PT81814B (pt) Processo para a preparacao de derivados de naftaleno
IE801162L (en) Pharmaceutical compositions
NO855204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.
KR890003691A (ko) 피페리딘 유도체 및 그를 함유하는 부정맥을 위한 치료예방제
JPS54154766A (en) Novel imidazole derivative*its manufacture and medicine containing said derivative and having antiiinflammatory and antiiallergic activity
ATE52506T1 (de) Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.
KR940003953A (ko) 1. 4-벤조디옥산 유도체
DE3363553D1 (en) Substituted alpha-(ethyl)-alpha-(phenyl)-(omega-(dialkylamino)-alkoxy)-benzyl alcohols, their acid addition salts and quaternary salts, process for their preparation, as well as medicines containing these compounds
MX9405111A (es) Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina).
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
ES543802A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
SE8903312D0 (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
HU895522D0 (en) Process for the preparation of new thienyl-oxy-alkyl-amine derivatives and pharmaceutical compositions containing them
NO862494D0 (no) Fremgangsmaate for fremstilling av nye aromatiske forbindelser.
EP0373591A3 (de) Polyhydroxybenzyloxypropanolamine
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
PT97885A (pt) Processo para a preparacao de derivados da {(1-aril-2-pirrolidinil)-metil-piperazina e de composicoes farmaceuticas que os contem
KR870006898A (ko) 신장염 치료제
ATE95697T1 (de) Uricosuretische zusammensetzung.
KR910011258A (ko) 녹내장의 치료방법
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee